We generalized our findings with lymphoma cell lines Raji and Daudi, and melanoma cell line A375-CD19 to show that our results are applicable across solid/liquid tumor types and further emphasize the redundancy of these cytotoxic mechanisms by mapping the co-expression of GZMB and GZMA in patient infusion products. The gene discussed is GZMB; the disease is melanoma.